Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype

Cytokine

Volumn 58, Issue 3, 2012, Pages 398-405

  Tuttolomondo, Antonino ^a   Di Raimondo, Domenico ^a   Forte, Giusi Irma ^a   Casuccio, Alessandra ^a   Vaccarino, Loredana ^a   Scola, Letizia ^a   Pecoraro, Rosaria ^a   Serio, Antonia ^a   Clemente, Giuseppe ^a   Arnao, Valentina ^a   Palmeri, Marisa ^a   Misiano, Gabriella ^a   Lio, Domenico ^a   Pinto, Antonio ^a   Licata, Giuseppe ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cytokines; Single nucleotide polymorphisms (SNPs); Stroke

Indexed keywords

GENOMIC DNA;

AGED; ARTICLE; BRAIN ISCHEMIA; CAUCASIAN; CONTROLLED STUDY; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; IL 10 GENE; IL 6 GENE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TNF ALPHA GENE; TPA GENE; VARIABLE NUMBER OF TANDEM REPEAT;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ALLELES; BASE SEQUENCE; BRAIN ISCHEMIA; DNA PRIMERS; FEMALE; FIBRINOLYSIS; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84860330854     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.02.012     Document Type: Article

References (50)

1. Nakase T., Yamazaki T., Ogura N., Suzuki A., Nagata K. The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Neurol Sci 2008, 271(1-2):104-109.
2. Herrmann S.M., Ricard S., Nicaud V., Mallet C., Arveiler D., Evans A., et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 1998, 1:59e66.
3. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997, 94:3195e9.
4. Um J.Y., An N.H., Kim H.M. TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci 2003, 21:167e71.
5. Um J.Y., Kim H.M. Tumor necrosis factor alpha gene polymorphism is associated with cerebral infarction. Brain Res Mol Brain Res 2004, 122:99e102.
6. Lee B.C., Ahn S.Y., Doo H.K., Yim S.V., Lee H.J., Jin S.Y., et al. Susceptibility for ischemic stroke in Korean population is associated with polymorphisms of the interleukin-1 receptor antagonist and tumor necrosis factor-alpha genes, but not the interleukin-1beta gene. Neurosci Lett 2004, 1:33e6.
7. Hoppe C., Klitz W., D'Harlingue K., Cheng S., Grow M., Steiner L., et al. Stroke prevention trial in sickle cell anemia (STOP) Investigators confirmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke. 2007, 38(8):2241-2246.
8. Hatano S. Experience from a multicenter Stroke register; a preliminary report. Bull World Health Organ 1976, 54:541e53.
9. Banerjee I., Gupta V., Ganesh S. Association of gene polymorphism with genetic susceptibility to stroke in Asian populations: a meta-analysis. J Hum Genet 2007, 52(3):205-219.
10. Strle K., Zhou J.H., Shen W.H., et al. Interleukin-10 in the brain. Crit Rev Immunol 2001, 21:427-449.
11. Reuss E., Fimmers R., Kruger A., Becker C., Rittner C., Hohler T. Differential regulation of interleukin-10 production by genetic and environmental factors-a twin study. Genes Immun 2002, 407-413:13.
12. Yilmaz V., Yentur S.P., Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005, 30(188-194):14.
13. Capasso M., Avvisati R.A., Piscopo C., Laforgia N., Raimondi F., de Angelis F., et al. Cytokine gene polymorphisms in Italian preterm infants: association between interleukin-10 -1082 G/A polymorphism and respiratory distress syndrome. Pediatr Res 2007, 61:313-317.
14. Lowe P.R., Galley H.F., Abdel-Fattah A., Webster N.R. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 2003, 31:34-38.
15. Reiner A.P., Wurfel M.M., Lange L.A., Carlson C.S., Nord A.S., Carty C.L., et al. Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arterioscler Thromb Vasc Biol 2008, 28(7):1407-1412.
16. Attia J., Thakkinstian A., Wang Y., Lincz L., Parsons M., Sturm J., et al. Levi C.J. The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis. Stroke Cerebrovasc Dis 2007, 16(4):173-179.
17. Tsantes A.E., Nikolopoulos G.K., Bagos P.G., Tsiara C.G., Kapsimali V., Travlou A. Vaiopoulos plasminogen activator inhibitor-1 4G/5G polymorphism and risk of ischemic stroke: a meta-analysis. G Blood Coagul Fibrinolysis 2007, 18(5):497-504.
18. Adams H.P., Bendixen B.H. Kappelle J, Biller J, Love B, Gordon M.D., Marsh E.E. and the TOAST Investigators. Classification of subtype of acute ischemic stroke. Stroke 1993, e24:358.
19. Rivero E.R., Neves A.C., Silva-Valenzuela M.G., Sousa S.O., Nunes F.D. Simple salting-out method for DNA extraction from formalin-fixed, paraffin-embedded tissues. Pathol Res Pract 2006, 202(7):523-529.
20. Forte G.I., Scola L., Misiano G., Milano S., Mansueto P., Vitale G., et al. Relevance of gamma interferon, tumor necrosis factor alpha, and interleukin-10 gene polymorphisms to susceptibility to Mediterranean spotted fever. Clin Vaccine Immunol 2009, 16(6):811-815.
21. Pes G.M., Lio D., Carru C., Deiana L., Baggio G., Franceschi C., et al. Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians. Aging Clin Exp Res 2004, 16:244-248.
22. Naran N.H., Chetty N., Crowther N.J. The influence of metabolic syndrome components on plasma PAI-1 concentrations is modified by the PAI-1 4G/5G genotype and ethnicity. Atherosclerosis 2008, 196:155-163.
23. Forte G.I., Calà C., Scola L., Crivello A., Gullo A., Marasà L., et al. Role of environmental and genetic factor interaction in age-related disease development: the gastric cancer paradigm. Rejuvenation Res 2008, 11(2):509-512.
24. Armstrong C.A., Bevan S.N., Gormley K.T., Markus H.S., Koblar S.A. Tissue plasminogen activator -7351C/T polymorphism and lacunar stroke. Stroke 2006, 37:329.
25. Bagnoli S., Cellini E., Tedde A., Nacmias B., Piacentini S., Bessi V., et al. Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer' disease. Neurosci Lett 2007, 418(3):262-265.
26. Yilmaz V., Yentur S.P., Saruhan-Direskeneli G. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005, 30:188-194.
27. Trompet S., Pons D., Craen A.J., Slagboom P., Shepherd J., Blauw G.J., et al. Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann NY Acad Sci 2007, 1100:189-198.
28. Spera P.A., Ellison J.A., Feuerstein G.Z. Barone FC.IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998, 251(3):189-192.
29. van Exel E., Gussekloo J., de Craen A.J., Bootsma-van der Wiel A., Frölich M., Westendorp R.G. Inflammation and stroke: the leiden 85-plus study. Stroke 2002 Apr, 33(4):1135-1138.
30. Balding J., Livingstone W.J., Pittock S.J., Mynett-Johnson L., Ahern T., Hodgson A., et al. The IL-6 G-174C polymorphism may be associated with ischaemic stroke in patients without a history of hypertension. Ir J Med Sci 2004, 173(4):200-203.
31. Karahan Z.C., Deda G., Sipahi T., Elhan A.H., Akar N. TNF-α -308G/A and IL-6 -174 G/C polymorphisms in the Turkish pediatric stroke patients. Thromb Res 2005, 115(5):393-398.
32. Arend W.P. The balance between IL-1 and IL-1ra in disease. Cytokine Growth Factor Rev 2002, 13:323-340.
33. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404(398-402):13.
34. Santtila S., Savinainen K., Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1- production in vitro. Scand J Immunol 1998, 47:195-198.
35. Hurme M., Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1ra and IL-1 genes. Eur J Immunol 1998, 28:2598-2602.
36. Andus T., Daig R., Vogl D., Aschenbrenner E., Lock G., Hollerbach S., et al. Imbalance of the interleukin 1 system in colonic mucosa-association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2. Gut 1997, 41:651-657.
37. Tountas N.A., Casini-Raggi V., Yang H., Di Giovine F.S., Vecchi M., Kam L., et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 1999, 117:806-813.
38. Onalan O., Balta G., Oto A., Kabakci G., Tokgozoglu L., Aytemir K., et al. Plasminogen activator inhibitor-1 4G4G genotype is associated with myocardial infarction but not with stable coronary artery disease. J Thromb Thrombolysis 2008 Dec, 26(3):211-217.
39. Roest M., van der Schouw Y.T., Banga J.D., Tempelman M.J., de Groot P.G., Sixma J.J., et al. Plasminogen activator inhibitor 4G polymorphism is associated with decreased risk of cerebrovascular mortality in older women. Circulation 2000, 101:67-70.
40. Elbaz A., Cambien F., Amarenco P. GENIC investigators. Plasminogen activator inhibitor genotype and brain infarction. Circulation 2001, 103(2):e13-e14.
41. Ladenvall P., Wall U., Jern S., Jern C. Identification of eight novel single nucleotide polymorphisms at human tissue-type plasminogen activator (t-PA) locus: association with vascular t-PA release in vivo. Thromb Haemos 2000, 84:150-155.
42. Jannes J., Hamilton-Bruce M.A., Pilotto L., Smith B.J., Mullighan C.G., Bardy P.G., et al. Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke. Stroke 2004, 35:1090-1094.
43. Jannes J., Hamilton-Bruce M.A., Pilotto L., Smith B.J., Mullighan C.J., Bardy P.G., et al. Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke. Stroke 2004, 35:1090-1109.
44. Balta G., Altay C., Gurgey A. PAI-1 gene 4G/5G genotype: a risk factor for thrombosis in vessels of internal organs. Am J Hematol 2002, 71:89-93.
45. Sartori M.T., Wiman B., Vettore S., Dazzi F., Girolami A., Patrassi G. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. J Thromb Haemost 1998, 80:956-960.
46. Stegnar M., Uhrin P., Peternel P., Mavri A., Salobir-Pajnic B., Stare J., et al. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Thromb Haemost 1998, 79(5):975-979.
47. Tuttolomondo A., Di Sciacca R., Di Raimondo D., Serio A., D'Aguanno G., La Placa S., et al. Pinto A Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J Neuroimmunol 2009, 215(1-2):84-89.
48. Licata G., Tuttolomondo A., Di Raimondo D., Corrao S., Di Sciacca R., Pinto A., et al. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb Haemost 2009, 101:929-937.
49. Harcos P., Laki J., Kiszel P., Széplaki Z., Szolnoki Z., Kovács M., et al. Decreased frequency of the TNF2 allele of TNF-α-308 promoter polymorphism is associated with lacunar infarction. Cytokine 2006, 33(2):100-105.
50. Hoekstra Tiny, Geleijnse Johanna M., Kluft Cornelis, Giltay Erik J., Kok Frans J., Schouten Evert G. 4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly. Stroke 2003, 34:2822.